Search

Products meeting the search criteria

Responding to FDA Form 483 Observations: What FDA Expects in 2026

Responding to FDA Form 483 Observations: What FDA Expects in 2026

Overview: Receiving a Form FDA 483 at the conclusion of an inspection can put an organization ..

Date : 28th October 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

Audit Trail Review by Exception in FDA-Regulated Environments: Reducing Review Burden While Strengthening Data Integrity

Audit Trail Review by Exception in FDA-Regulated Environments: Reducing Review Burden While Strengthening Data Integrity

Overview Audit trails are essential to maintaining trustworthy electronic records in FDA-regu..

Date : 28th August 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

CAPA Under QMSR: Root Cause, Risk, and Effectiveness Verification

CAPA Under QMSR: Root Cause, Risk, and Effectiveness Verification

Overview: CAPA is one of the most closely examined parts of a medical device quality system, ..

Date : 23rd July 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 75 Mins

AI in Drug Development: FDA Compliance, Validation, and Data Integrity

AI in Drug Development: FDA Compliance, Validation, and Data Integrity

Overview: Artificial Intelligence is no longer sitting at the edge of drug development. It is ..

Date : 24th June 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

Best Practices for FDA Computer System Audit Preparation in 2026

Best Practices for FDA Computer System Audit Preparation in 2026

Overview: For those of us who have worked around FDA-regulated computer systems for many year..

Date : 29th May 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

The 6 Most Common Problems in FDA Software Validation and Verification in 2026

The 6 Most Common Problems in FDA Software Validation and Verification in 2026

Overview: Software validation and verification remain common sources of compliance risk for F..

Date : 14th May 2026

Time : This Event is Over

Duration : 75 Mins

Quality Management System Regulation (QMSR) – Replacement of QSR and Alignment with ISO

Quality Management System Regulation (QMSR) – Replacement of QSR and Alignment with ISO

Overview: Effective February 2, 2026, FDA’s Quality Management System Regulation (QMSR) became..

Date : 23rd April 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

Prepare for FDA QMSR Inspections: 483 & Warning Letter Response

Prepare for FDA QMSR Inspections: 483 & Warning Letter Response

Overview: FDA inspections under the new QMSR can look and feel different—not just in what inv..

Date : 23rd February 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 60 Mins

Risk-Based Excel Spreadsheet Validation and FDA Compliance - Risk-Based CSV/CSA & Part 11

Risk-Based Excel Spreadsheet Validation and FDA Compliance - Risk-Based CSV/CSA & Part 11

Overview:FDA inspections and audits continue to put a bright spotlight on data integrity—especiall..

Date : 27th January 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

FDA’s QMSR is Coming: Practical Readiness for Quality Teams

FDA’s QMSR is Coming: Practical Readiness for Quality Teams

Overview: With the FDA’s Quality Management System Regulation (QMSR) taking effect in February..

Date : 21st January 2026

Time : This Event is Over and the Recorded Content is Available

Duration : 60 Mins

Excel Spreadsheet in FDA Regulated Environment - Validating Excel for GxP & 21 CFR Part 11

Excel Spreadsheet in FDA Regulated Environment - Validating Excel for GxP & 21 CFR Part 11

Overview: The use of Excel in FDA-regulated environments goes far beyond basic analysis. When ..

Date : 21st November 2025

Time : This Event is Over

Duration : 75 Mins

Clinical Trial Systems: Trial Master File (TMF) and eTMF, & FDA’s Recent Draft Guidance for Electronic Records/Signatures Used in Clinical Trials

Clinical Trial Systems: Trial Master File (TMF) and eTMF, & FDA’s Recent Draft Guidance for Electronic Records/Signatures Used in Clinical Trials

Overview: Organizations involved in the conduct of human clinical trials must meet rigorous re..

Date : 30th September 2025

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

Best Practices in Preparation for an FDA Computer System Audit in 2025

Best Practices in Preparation for an FDA Computer System Audit in 2025

Overview: In 2025, the FDA's expectations for validated computer systems have never been high..

Date : 31st July 2025

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

Best Practices for Responding to a Form 483 Citation and/or Warning Letter Issued by FDA in 2025

Best Practices for Responding to a Form 483 Citation and/or Warning Letter Issued by FDA in 2025

Overview: The U.S. Food and Drug Administration (FDA) plays a critical role in safeguarding pub..

Date : 27th June 2025

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

Business Process Mapping – How to Prepare a Detailed System & Data Roadmap for a Clinical Trial Regulated by FDA

Business Process Mapping – How to Prepare a Detailed System & Data Roadmap for a Clinical Trial Regulated by FDA

Overview: Conducting human clinical trials requires strict adherence to government regulatory ..

Date : 30th October, 2024

Time : This Event is Over and the Recorded Content is Available

Duration : 90 Mins

Showing 1 to 15 of 19 (2 Pages)